Background illustration for clinical trials search

Paid Clinical Trials Tuscaloosa

Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

for
Mid Face Volume Deficit
Location: Birmingham AL, Atlanta GA, Metairie LA, Bradenton FL,
Sponsor: AbbVie

Sex: All

Age: 22+

Code: NCT06734351

Phase3, Recruiting
FeaturedActive & Responsive

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

for
Migraine
Location: Birmingham AL, Summerville SC, Tampa FL, Austin TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70

Code: NCT06602479

Phase2, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Birmingham AL, Columbus GA, Dawsonville GA,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting
Active & Responsive

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

for
Major Depressive Disorder
Location: Birmingham AL, Savannah GA, Jacksonville FL, Orlando FL,
Sponsor: Syndeio Biosciences, Inc

Sex: All

Age: 18 - 64

Code: NCT06547489

Phase2, Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: Birmingham AL, Louisville KY, New Albany IN,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Birmingham AL, Atlanta GA, Macon GA, Louisville KY,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants

for
Alopecia Areata
Location: Birmingham AL, Nashville TN, Louisville KY,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05865041

Phase2, Recruiting

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

for
Familial Chylomicronemia Syndrome
Location: Birmingham AL, Dallas TX, Fort Worth TX,
Sponsor: Ionis Pharmaceuticals, Inc.

Sex: All

Age: 2 - 17

Code: NCT07727538

Phase3, Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Birmingham AL, Huntsville AL, Atlanta GA, Nashville TN,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

for
Breast Cancer, Metastatic Breast Cancer
Location: Birmingham AL, Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06855654

Recruiting

A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction

for
Lung Transplant Rejection
Location: Birmingham AL, Atlanta GA, Nashville TN,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06082037

Phase3, Recruiting

Effects of Spinal Cord Injury on Female Sexual Response

for
Female Sexual Dysfunction, Multiple Sclerosis,
Location: Birmingham AL
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Sex: Female

Age: 18 - 55

Code: NCT00142714

Recruiting

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for
Aortic Stenosis
Location: Birmingham AL, Nashville TN, Cincinnati OH,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18 - 70+

Code: NCT06777368

Recruiting

A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy

for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Birmingham AL, Pensacola FL, Decatur IL, Kansas City MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07091019

Recruiting

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

for
Invasive Mould Infection
Location: Birmingham AL, Augusta GA, St Louis MO, Houston TX,
Sponsor: Elion Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07215273

Phase2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Birmingham AL, Adairsville GA, Chattanooga TN,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190222

Phase3, Recruiting

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

for
Chronic Obstructive Pulmonary Disease
Location: Birmingham AL, Cordele GA, Charlotte NC, Beaumont TX,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07053423

Recruiting

Study of NTB-928 in R/R OC

for
Relapsed/Refractory Ovarian Carcinoma
Location: Birmingham AL, Fort Worth TX, Omaha NE, Lake Success NY
Sponsor: TeneoSeven, Inc.

Sex: Female

Age: 18+

Code: NCT07690189

Phase1, Recruiting

Pompe Disease Registry Protocol

for
Glycogen Storage Disease Type II, Pompe Disease
Location: Birmingham AL, Decatur GA, Nashville TN, Little Rock AR,
Sponsor: Genzyme, a Sanofi Company

Sex: All

Age: 0+

Code: NCT00231400

Recruiting

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

for
Sickle Cell Disease
Location: Birmingham AL, Flowood MS, Greenville SC, Shreveport LA,
Sponsor: Sanofi

Sex: All

Age: 10 - 65

Code: NCT06975865

Phase3, Recruiting